Objective Atypical manifestations have been described in patients with ANCA-associated
vasculitides (AAV), such as pachymeningitis, orbital mass or chronic periaortitis. Because …

Background Cogan syndrome is mainly treated with steroids. We aimed to determine the
place of DMARDs and biologic-targeted treatments. Patients and methods We conducted a …

We wanted to describe the characteristics, treatment and outcome of autoimmune and
inflammatory diseases (SAIDs) associated with chronic myelomonocytic leukemia (CMML), and …

Objective. We describe myelodysplastic syndrome (MDS)–associated systemic inflammatory
and autoimmune diseases (SIADs), their treatments and outcomes and the impact of SIADs …

Aim The growing use of immune checkpoint inhibitors (ICIs) is associated with the
occurrence of immune-related adverse events (irAEs). Few data are published on systemic, …

Objective Data on adult IgA vasculitis (Henoch‐Schönlein) (IgAV) are scarce. This survey
was designed to better define the clinical spectrum of IgAV and efficacy of treatments in a …

The aim of the study was to assess the efficacy and safety of rituximab (RTX) for treating
systemic lupus erythematosus (SLE)‐associated immune cytopenias. This multicenter …

Objectives To assess the efficacy of tocilizumab in patients with Takayasu arteritis (TA).
Methods We conducted a retrospective multicenter study in 46 TA patients treated with …

Objective To assess the safety and the efficacy of TNF-α antagonists and tocilizumab in
patients with Takayasu arteritis (TAK). Methods A total of 209 patients with TAK [median age 29 …

Objectives To assess long-term efficacy of tocilizumab in treatment-naive patients with
Takayasu arteritis (TAK). Methods Prospective open-labeled trial in naïve patients with TAK who …